Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gallant
San Diego, California, United States
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Gallant is a clinical-stage animal health biotechnology company developing off-the-shelf allogeneic mesenchymal stem cell therapies for dogs and cats, with a lead program for refractory feline chronic gingivostomatitis in a pivotal study and targeting conditional FDA approval around early 2026, supported by multiple positive pilot studies and ongoing controlled field studies.[6][7][8]
- Therapeutic areas
- NephrologyImmunologyRheumatologyDermatology
- Modalities
- Cell therapyStem cell therapyBiologic
- Industry
- Veterinary
02
Partnerships
Acquisition of veterinary division of Cook-Regentec including stem cell banking operations and pipeline assets (strategic technology and IP partnership via acquisition)[4]Clinical and commercial collaborations with veterinary practices across the U.S. for field and pivotal studies (multi-site veterinary network)[6][7]
Beyond the preview
Go deeper on Gallant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gallant.